200 related articles for article (PubMed ID: 25765519)
1. A systematic review of dydrogesterone for the treatment of recurrent miscarriage.
Carp H
Gynecol Endocrinol; 2015 Jun; 31(6):422-30. PubMed ID: 25765519
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of dydrogesterone for the treatment of threatened miscarriage.
Carp H
Gynecol Endocrinol; 2012 Dec; 28(12):983-90. PubMed ID: 22794306
[TBL] [Abstract][Full Text] [Related]
3. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
[TBL] [Abstract][Full Text] [Related]
4. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
[TBL] [Abstract][Full Text] [Related]
5. Dydrogesterone in threatened miscarriage: a Malaysian experience.
Pandian RU
Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
[TBL] [Abstract][Full Text] [Related]
6. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.
Kuptarak A; Phupong V
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2333929. PubMed ID: 38570191
[TBL] [Abstract][Full Text] [Related]
7. Dydrogesterone use in early pregnancy.
Mirza FG; Patki A; Pexman-Fieth C
Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
[TBL] [Abstract][Full Text] [Related]
8. The role of dydrogesterone in recurrent (habitual) abortion.
Gruber CJ; Huber JC
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):426-30. PubMed ID: 16188436
[TBL] [Abstract][Full Text] [Related]
9. Progestogens in the prevention of miscarriage.
Carp HJ
Horm Mol Biol Clin Investig; 2016 Aug; 27(2):55-62. PubMed ID: 26677905
[TBL] [Abstract][Full Text] [Related]
10. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage.
Siew JYS; Allen JC; Hui CYY; Ku CW; Malhotra R; Østbye T; Tan TC
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():319-324. PubMed ID: 30077119
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis.
Lee HJ; Park TC; Kim JH; Norwitz E; Lee B
Biomed Res Int; 2017; 2017():3616875. PubMed ID: 29392134
[TBL] [Abstract][Full Text] [Related]
12. Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial.
Walch K; Hefler L; Nagele F
J Matern Fetal Neonatal Med; 2005 Oct; 18(4):265-9. PubMed ID: 16318978
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for threatened miscarriage.
Qureshi NS
Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
[TBL] [Abstract][Full Text] [Related]
14. Dydrogesterone support in threatened miscarriage.
El-Zibdeh MY; Yousef LT
Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of dydrogesterone on treating recurrent miscarriage and its influence on immune factors: a systematic review and meta-analysis.
Guo H; Lu Q
Ann Palliat Med; 2021 Oct; 10(10):10971-10985. PubMed ID: 34763460
[TBL] [Abstract][Full Text] [Related]
16. Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman's journey.
Stute P
Gynecol Endocrinol; 2021 Aug; 37(8):683-688. PubMed ID: 33866898
[TBL] [Abstract][Full Text] [Related]
17. Dydrogesterone in threatened abortion: pregnancy outcome.
Omar MH; Mashita MK; Lim PS; Jamil MA
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):421-5. PubMed ID: 16293412
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.
Chan DM; Cheung KW; Yung SS; Lee VC; Li RH; Ng EH
Trials; 2016 Aug; 17(1):408. PubMed ID: 27534747
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of progesterone on threatened miscarriage: Difference in drug types.
Wang XX; Luo Q; Bai WP
J Obstet Gynaecol Res; 2019 Apr; 45(4):794-802. PubMed ID: 30632226
[TBL] [Abstract][Full Text] [Related]
20. Dydrogesterone has no effect on uterine fibroids when used to prevent miscarriage in pregnant women with uterine fibroids.
Wang S; Wang XT; Liu RH; Liu M; Wu YR; Huang XY; Zhao N; Mu YL
Ginekol Pol; 2017; 88(12):679-685. PubMed ID: 29303226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
